Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Importance of pain management in cancer patients and survivors.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Opioid prescribing for acute postoperative pain: an overview of systematic reviews related to two consensus statements relevant at patient, prescriber, system and public health levels.

BMC anesthesiology·2023

Same author

Changing demographics of peri-operative patients: increases and decreases.

Anaesthesia·2023

Same author

Erector spinae plane block with catheter infusion for analgesia in a patient undergoing transaxillary first rib resection.

Anaesthesia reports·2022

Same author

[Ovarian teratoma in children. Clinical case and review of the literature].

Revue medicale de Liege·2022

Same author

[How I explore… hémostatic abnormalities in pediatrics].

Revue medicale de Liege·2021

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 19, 2013

[Acute lymphoblastic leukemia in children].

S Panizzoto¹, M F Dresse, V Schmitz

¹CHR Citadelle, Liège.

Revue Medicale De Liege

|March 18, 2005

Summary

This study analyzed 77 children with acute lymphoblastic leukemia (ALL) treated between 1985-2002. High survival rates were observed, with prognostic factors including sex, white blood cell count, and immunophenotype identified.

More Related Videos

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Related Experiment Videos

Last Updated: Jul 11, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 19, 2013

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Area of Science:

Pediatric Hematology-Oncology
Leukemia Research
Clinical Outcomes

Context:

Experience from the University of Liege Pediatric Department of Hematology-Oncology (1985-2002).
Study cohort includes seventy-seven children diagnosed with acute lymphoblastic leukemia (ALL).
Extended follow-up period averaging 6.7 years.

Purpose:

To report treatment outcomes for pediatric acute lymphoblastic leukemia (ALL).
To identify prognostic factors influencing survival in childhood ALL.
To evaluate long-term survival and disease-free survival rates.

Summary:

The study reports a 5-year overall survival of 83% and disease-free survival of 79% for pediatric ALL patients.
Key prognostic indicators identified include patient sex, elevated white blood cell counts at diagnosis, and specific immunophenotypes.
Treatment experience spans seventeen years, from 1985 to 2002.

Impact:

Provides valuable data on pediatric ALL treatment efficacy and long-term outcomes.
Highlights significant prognostic factors for risk stratification and personalized treatment strategies.
Contributes to the understanding of childhood leukemia management and survival improvements.